Top Markets
#1 Siren Siren +35.19%
#2 Ribbita by Virtuals Ribbita by Virtuals +25.01%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.98%
#4 Wiki Cat Wiki Cat +24.76%
#5 KUB Coin KUB Coin +17.57%
#6 PulseChain PulseChain +17.32%
#7 OpenEden OpenEden +16.88%
#8 BasedHype BasedHype +16.52%
#9 Cysic Cysic +16.32%
#10 Faith Tribe Faith Tribe +15.37%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rangering i aksjer #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Aksjekurs
$0.4018
Markedsverdi
$14.12M
Endring (1 dag)
-3.20%
Endring (1 år)
-88.15%
Land
US
Handel Skye Bioscience, Inc. (SKYE)

Kategori

Healthcare
Aksjeprishistorikk for Skye Bioscience, Inc. (SKYE)
Høyeste sluttskurs: $0.50 den 2026-08-01

Laveste sluttskurs: $2.50K den 2014-11-01
Aksjeprishistorikk for Skye Bioscience, Inc. fra 2014 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 27.56%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $532.21 36.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.00K 51.44%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.87%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 13.01%
BE